Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nadroparin PK in Morbidly Obese Bariatric Surgery Patients
NCT02295150Phase 4Unknown
- Sponsor
- Rijnstate
- Start
- Mar 2013
- Primary completion
- Jun 2015
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nadroparin in thromboembolism, sponsored by Rijnstate. Status: unknown.
02
Drugs
nadroparin
03
Conditions
thromboembolism
Beyond the preview
Go deeper on NCT02295150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02295150.